More stories on Th17 cells.

More stories on Th17 cells.
复制标题

DOI:
10.1038/cr.2009.26
复制
发表时间:
2009-04
期刊:
影响因子:
44.1
通讯作者:
--
中科院分区:
生物学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

二十多年来,免疫学家一直使用所谓的Th 1/Th 2范式来解释与适应性免疫相关的大多数现象。Th 1/Th 2模式意味着存在两种不同的相互调节的CD 4 + T辅助细胞亚群:Th 1细胞,驱动细胞介导的免疫应答,参与组织损伤和细胞内寄生虫感染; Th 2细胞介导IgE产生,特别参与嗜酸性粒细胞炎症、过敏和蠕虫感染的清除。辅助性T细胞的第三个成员,产生IL-17的CD 4 + T细胞,现在被称为Th 17细胞,最近被描述为一种独特的谱系,与Th 1或Th 2细胞不共享发育途径。Th 17亚群与自身免疫性疾病有关,能够产生IL-17、IL-17 F和IL-21以及其他炎性细胞因子。有趣的是,据报道,Th 1、Th 2和Th 17效应细胞之间不仅存在交叉调节,而且在Th 17和T调节细胞的产生中也存在二分法。因此,Treg和Th 17效应细胞以相互排斥的方式出现,这取决于它们是否在TGF-β或TGF-β加炎性细胞因子如IL-6的存在下被激活。本文就Th 17细胞的发现及其发育和调控的最新进展作一综述。
For more than two decades, immunologists have been using the so-called Th1/Th2 paradigm to explain most of the phenomena related to adaptive immunity. The Th1/Th2 paradigm implied the existence of two different, mutually regulated, CD4+ T helper subsets: Th1 cells, driving cell-mediated immune responses involved in tissue damage and infection against intracellular parasites; and Th2 cells that mediate IgE production and are particularly involved in eosinophilic inflammation, allergy and clearance of helminthic infections. A third member of the T helper set, IL-17-producing CD4+ T cells, now called Th17 cells, was recently described as a distinct lineage that does not share developmental pathways with either Th1 or Th2 cells. The Th17 subset has been linked to autoimmune disorders, being able to produce IL-17, IL-17F and IL-21 among other inflammatory cytokines. Interestingly, it has been reported that there is not only a cross-regulation among Th1, Th2 and Th17 effector cells but there is also a dichotomy in the generation of Th17 and T regulatory cells. Therefore, Treg and Th17 effector cells arise in a mutually exclusive fashion, depending on whether they are activated in the presence of TGF-β or TGF-β plus inflammatory cytokines such as IL-6. This review will address the discovery of the Th17 cells, and recent progress on their development and regulation.
T-BET的丧失,但不是STAT1阻止了实验性自身免疫性脑脊髓炎的发展。
DOI: 10.1084/jem.20031819
发表时间: 2004-07-05
影响因子: 15.3
作者:
Bettelli, E;Sullivan, B;Szabo, SJ;Sobel, RA;Glimcher, H;Kuchroo, VK
通讯作者: Kuchroo, VK
DOI: 10.1084/jem.20040249
发表时间: 2004-05-17
影响因子: 15.3
作者:
Apostolou, I;von Boehmer, H
通讯作者: von Boehmer, H
DOI: 10.1084/jem.186.6.867
发表时间: 1997-09-15
期刊: The Journal of experimental medicine
影响因子: --
作者:
Das MP;Nicholson LB;Greer JM;Kuchroo VK
通讯作者: Kuchroo VK
DOI: 10.1038/ni1496
发表时间: 2007-09-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Acosta-Rodriguez, Eva V.;Napolitani, Giorgio;Sallusto, Federica
通讯作者: Sallusto, Federica
DOI: 10.1038/nature04753
发表时间: 2006-05-11
期刊: NATURE
影响因子: 64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者: Kuchroo, VK